B.R.A.I.N. Biotechnology Research and Information Network AG („BRAIN AG“; ISIN DE0005203947 / WKN 520394) and DIANA Pet Food, world’s leading partner for performance solutions in the pet food industry, member of the Symrise Group, today announce the achievement of an important milestone within their strategic partnership in the field of cat taste science.
This CTC-technology is similar to the recently patented and published BRAIN human taste cell (HTC) technology, being used by BRAIN for screening purposes to improve human food formulations in order to reduce calorie (sugar/fat) and salt intake with the diet. Nonetheless, human taste cell lines cannot be used for screening purposes in order to improve pet food palatability, as it is well accepted that human taste and flavour perceptions is far different from that of cats and dogs.
“We are very happy that, in only a few months, our strategic partnership with BRAIN allowed achieving that important milestone. This is a valid basis for the next steps in our joint program,” says Isabelle Guiller, Global R&D Director at DIANA Pet Food. “Palatability performance strongly depends on the interaction between food properties, pet sensory equipment and individual preferences. That is why we believe that the CTC-technology is a promising and potent method to increase our knowledge on cat taste mechanisms. Combined with sensorial testing in animal panels, it will enable us developing increasingly more powerful palatants satisfying cats, thus their owners.”
Dr. Michael Krohn, Executive VP at BRAIN AG states: “It is great to see that we were able to achieve that important milestone ahead of time. It was of great help for us, though, to transfer the knowledge we achieved on the human taste cell line technology during the last years on the cat taste cells. To our knowledge together with our strategic partner DIANA Pet Food we are the only ones in the world having this novel CTC-technology in place.”
The French version of this Press Release can be found under the following link:
La version française de cette communiqué de presse est situé à l’adresse suivante: